BIOFIL CHEMICALS & PHARMACEUTICALS LTD. Q1 FY27 Results
BIOFILCHEMQ1 FY27 ResultsAnnounced 11 Aug, 6:08 pmResult:Steady· Market: Flat#Base effect
| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 12.35 | 63.2% | 92.0% |
| Total Income | 12.41 | 61.8% | 34.0% |
| Expenditure | 12.28 | 70.4% | 88.8% |
| PBT | 0.13 | 71.4% | 95.2% |
| Net Profit | 0.11 | 48.6% | 95.5% |
| OPM | 1.14% | 4.60pp | 1.05pp |
| NPM | 0.88% | 1.89pp | 25.14pp |
| EPS | 0.07 | 46.1% | 95.3% |
Revenue grew a strong 92% YoY and OPM ticked up (0.09%→1.14%), but the 95.5% PAT crash is a base-effect artifact from ₹2.83cr of one-off other income in the year-ago quarter — stripping that out, core PBT actually turned marginally positive from a small core loss, leaving an ordinary, wafer-thin-margin quarter with no real standout.
Informational and educational content only. Not investment advice.